InvestorsHub Logo
Followers 62
Posts 7601
Boards Moderated 1
Alias Born 01/02/2003

Re: TalShu post# 413870

Monday, 08/14/2023 7:39:55 PM

Monday, August 14, 2023 7:39:55 PM

Post# of 428687
Craig Granowitz was appointed chief medical officer of Amarin in Jan of 2016..He was aware of the deal between Amarin and Mochida in 2015, which provided opportunities for Amarin to work on new products containing EPA...Granowitz and Ketchum were definitely aware of MND-2119...and yet, even after the Marine patent was invaldated in 2020 allowing Generics to infringe on its CVD patent, Amarin has still done nothing to 'collaborate' with Mochida on a clearly superior, emulsified form of EPA....IMO, this alone was reason enough to necessitate the recent change in management...I hope that this policy of inaction does not persist with present management.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News